![Elias Papatheodorou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elias Papatheodorou
Director Ejecutivo en
Calliditas Therapeutics Suisse SA
.
Perfil
Elias Papatheodorou is currently Chief Executive Officer & Director at Calliditas Therapeutics Suisse SA since 2015.
Since 2022, holds the position of Chief Executive Officer & Managing Director at HepaRegeniX GmbH, with the managing director title starting in 2024.
Also serves as Director at Tribune Therapeutics AB. Former roles include Chief Executive Officer at Novosom Verwaltungs GmbH from 2004 to 2009, Chief Executive Officer at Genticel SA, Chief Executive Officer & Director at Calliditas Therapeutics France SAS from 2017 to 2021, Chairman at Priaxon AG, Independent Chairman at Memo Therapeutics AG, Senior VP-Business Development & Operations at MediGene AG, Principal at Philip Morris USA, Inc., and Chief Business Officer at Covagen AG.
Education includes undergraduate studies at Ithaca College and graduate studies at Cornell University.
Cargos activos de Elias Papatheodorou
| Empresas | Cargo | Inicio |
|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Director Ejecutivo | - |
HepaRegeniX GmbH
 HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases | Director Ejecutivo | 22/10/2024 |
Tribune Therapeutics AB
 Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Elias Papatheodorou.
| Empresas | Cargo | Fin |
|---|---|---|
Memo Therapeutics AG
 Memo Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer | Presidente | 08/07/2024 |
| GENKYOTEX SA. | Director Ejecutivo | 01/12/2021 |
Genticel SA
 Genticel SA BiotechnologyHealth Technology Develops vaccines for patients infected with human papillomavirus | Director Ejecutivo | - |
Priaxon AG
 Priaxon AG Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company for small molecule therapeutics | Presidente | - |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Develops next generation protein drugs for the treatment of inflammatory diseases and cancer | Corporate Officer/Principal | - |
Formación de Elias Papatheodorou.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
30
Relaciones de 1er grado
13
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 13 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Ithaca College
 Ithaca College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philip Morris USA, Inc.
 Philip Morris USA, Inc. TobaccoConsumer Non-Durables Manufactures and distributes cigarettes and related tobacco products | Consumer Non-Durables |
Priaxon AG
Priaxon AG Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company for small molecule therapeutics | Commercial Services |
Novosom Verwaltungs GmbH
 Novosom Verwaltungs GmbH BiotechnologyHealth Technology Develops liposomal technology for the delivery of DNA based therapeutics | Health Technology |
Genticel SA
Genticel SA BiotechnologyHealth Technology Develops vaccines for patients infected with human papillomavirus | Health Technology |
Covagen AG
Covagen AG BiotechnologyHealth Technology Develops next generation protein drugs for the treatment of inflammatory diseases and cancer | Health Technology |
Memo Therapeutics AG
Memo Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer | Health Technology |
HepaRegeniX GmbH
HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases | Health Technology |
Calliditas Therapeutics France SAS
 Calliditas Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development | Commercial Services |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Commercial Services |
- Bolsa de valores
- Insiders
- Elias Papatheodorou
